Concurrent Taxol (Paclitaxel) and Definitive Breast Radiation Therapy in Early Stage Breast Cancer Following Four Cycles of Adriamycin/Cytoxan Chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2016
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin
- Indications Breast cancer
- Focus Therapeutic Use
- 01 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2017.
- 24 Jul 2015 Planned end changed from 1 Nov 2015 to 1Jul 2016 as reported by ClinicalTrials.gov record.
- 13 Jun 2011 Additional lead trial investigator (Paula Silverman) identified as reported by ClinicalTrials.gov.